Sophia Genetics (SOPH) said Tuesday George Cardoza has joined the company as chief financial officer.
Cardoza succeeds Ross Muken, who will serve as president of the company, effective Tuesday. Muken was also chief operating officer of Sophia prior to his new appointment.
Candoza most recently served as CFO and head of service delivery at molecular diagnostics company Biocartis.
Price: 3.53, Change: -0.22, Percent Change: -5.87
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.